Literature DB >> 22988875

LRRK2 and vesicle trafficking.

Giovanna Sanna1, Maria Grazia Del Giudice, Claudia Crosio, Ciro Iaccarino.   

Abstract

Mutations in LRRK2 (leucine-rich repeat kinase 2) (also known as PARK8 or dardarin) are responsible for the autosomal-dominant form of PD (Parkinson's disease). LRRK2 mutations were found in approximately 3-5% of familial and 1-3% of sporadic PD cases with the highest prevalence (up to 40%) in North Africans and Ashkenazi Jews. To date, mutations in LRRK2 are a major genetic risk factor for familial and sporadic PD. Despite the fact that 8 years have passed from the establishment of the first link between PD and dardarin in 2004, the pathophysiological role of LRRK2 in PD onset and progression is far from clearly defined. Also the generation of different LRRK2 transgenic or knockout animals has not provided new hints on the function of LRRK2 in the brain. The present paper reviews recent evidence regarding a potential role of LRRK2 in the regulation of membrane trafficking from vesicle generation to the movement along cytoskeleton and finally to vesicle fusion with cell membrane.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988875     DOI: 10.1042/BST20120117

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  9 in total

1.  Role of LRRK2 in the regulation of dopamine receptor trafficking.

Authors:  Mauro Rassu; Maria Grazia Del Giudice; Simona Sanna; Jean Marc Taymans; Michele Morari; Alberto Brugnoli; Martina Frassineti; Alessandra Masala; Sonia Esposito; Manuela Galioto; Cristiana Valle; Maria Teresa Carri; Alice Biosa; Elisa Greggio; Claudia Crosio; Ciro Iaccarino
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

Review 2.  LRRK2 Phosphorylation, More Than an Epiphenomenon.

Authors:  Antoine Marchand; Matthieu Drouyer; Alessia Sarchione; Marie-Christine Chartier-Harlin; Jean-Marc Taymans
Journal:  Front Neurosci       Date:  2020-06-16       Impact factor: 4.677

3.  LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis.

Authors:  Chi G Weindel; Samantha L Bell; Krystal J Vail; Kelsi O West; Kristin L Patrick; Robert O Watson
Journal:  Elife       Date:  2020-02-14       Impact factor: 8.140

4.  A dual inhibitor targeting HMG-CoA reductase and histone deacetylase mitigates neurite degeneration in LRRK2-G2019S parkinsonism.

Authors:  Chin-Hsien Lin; Han-Yi Lin; Jim-Min Fang; Ching-Chow Chen
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

5.  Deletion of lrrk2 causes early developmental abnormalities and age-dependent increase of monoamine catabolism in the zebrafish brain.

Authors:  Stefano Suzzi; Reiner Ahrendt; Stefan Hans; Svetlana A Semenova; Avinash Chekuru; Paul Wirsching; Volker Kroehne; Saygın Bilican; Shady Sayed; Sylke Winkler; Sandra Spieß; Anja Machate; Jan Kaslin; Pertti Panula; Michael Brand
Journal:  PLoS Genet       Date:  2021-09-13       Impact factor: 5.917

6.  LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization.

Authors:  Rossana Migheli; Maria Grazia Del Giudice; Ylenia Spissu; Giovanna Sanna; Yulan Xiong; Ted M Dawson; Valina L Dawson; Manuela Galioto; Gaia Rocchitta; Alice Biosa; Pier Andrea Serra; Maria Teresa Carri; Claudia Crosio; Ciro Iaccarino
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

7.  Surfactant secretion in LRRK2 knock-out rats: changes in lamellar body morphology and rate of exocytosis.

Authors:  Pika Miklavc; Konstantin Ehinger; Kristin E Thompson; Nina Hobi; Derya R Shimshek; Manfred Frick
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

8.  Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO Proteins.

Authors:  James E Tomkins; Sybille Dihanich; Alexandra Beilina; Raffaele Ferrari; Nicolò Ilacqua; Mark R Cookson; Patrick A Lewis; Claudia Manzoni
Journal:  Proteomics       Date:  2018-04-17       Impact factor: 3.984

Review 9.  From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson's Disease: Lessons From LRRK2.

Authors:  Andrea Mancini; Petra Mazzocchetti; Miriam Sciaccaluga; Alfredo Megaro; Laura Bellingacci; Dayne A Beccano-Kelly; Massimiliano Di Filippo; Alessandro Tozzi; Paolo Calabresi
Journal:  Front Cell Neurosci       Date:  2020-07-28       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.